Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Autolus Therapeutics (AUTL) Other Gross PP&E Adjustments (2017 - 2025)

Autolus Therapeutics' Other Gross PP&E Adjustments history spans 9 years, with the latest figure at -$40.1 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments changed 0.13% year-over-year to -$40.1 million; the TTM value through Dec 2025 reached -$40.1 million, changed 0.13%, while the annual FY2025 figure was -$40.1 million, 0.13% changed from the prior year.
  • Other Gross PP&E Adjustments reached -$40.1 million in Q4 2025 per AUTL's latest filing, up from -$41.5 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $10.5 million in Q4 2021 to a low of -$67.4 million in Q4 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$33.8 million, with a median of -$40.1 million recorded in 2025.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 119.62% in 2021, then tumbled 2081.22% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $10.5 million in 2021, then tumbled by 67.64% to $3.4 million in 2022, then crashed by 2081.22% to -$67.4 million in 2023, then soared by 40.5% to -$40.1 million in 2024, then grew by 0.13% to -$40.1 million in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Other Gross PP&E Adjustments are -$40.1 million (Q4 2025), -$41.5 million (Q3 2025), and -$56.0 million (Q2 2025).